Clinical trial
Comparative Effectiveness of Point-of-care Glycosylated Hemoglobin Measurement (POC-A1c) vs the Current Standard Based on Oral Glucose Tolerance Test for Early Detection of Type 2 Diabetes Mellitus (DM2) in Colombia
NCT05440968 is registered in ClinicalTrials.gov with Humberto Reynales MD MSc PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Effectiveness of Point-of-care Glycosylated Hemoglobin Measurement (POC-A1c) vs the Current Standard Based on Oral Glucose Tolerance Test for Early Detection of Type 2 Diabetes Mellitus (DM2) in Colombia
- Lead sponsor
- Humberto Reynales MD MSc PhD
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2022
- Completion date
- September 20, 2023
- Enrollment
- 902 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.